NL8701994A - Toepassing van n-(2-hydroxyethyl)nicotinamidenitraat of een farmaceutisch acceptabel zout hiervan ter bereiding van een geneesmiddel. - Google Patents
Toepassing van n-(2-hydroxyethyl)nicotinamidenitraat of een farmaceutisch acceptabel zout hiervan ter bereiding van een geneesmiddel. Download PDFInfo
- Publication number
- NL8701994A NL8701994A NL8701994A NL8701994A NL8701994A NL 8701994 A NL8701994 A NL 8701994A NL 8701994 A NL8701994 A NL 8701994A NL 8701994 A NL8701994 A NL 8701994A NL 8701994 A NL8701994 A NL 8701994A
- Authority
- NL
- Netherlands
- Prior art keywords
- cerebral
- active substance
- hydroxyethyl
- compound
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19879686 | 1986-08-27 | ||
| JP19879686 | 1986-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8701994A true NL8701994A (nl) | 1988-03-16 |
Family
ID=16397046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8701994A NL8701994A (nl) | 1986-08-27 | 1987-08-26 | Toepassing van n-(2-hydroxyethyl)nicotinamidenitraat of een farmaceutisch acceptabel zout hiervan ter bereiding van een geneesmiddel. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4870090A (ja) |
| JP (1) | JPH07121863B2 (ja) |
| KR (1) | KR950002151B1 (ja) |
| AU (1) | AU603375B2 (ja) |
| BE (1) | BE1003959A5 (ja) |
| CA (1) | CA1302888C (ja) |
| CH (1) | CH672069A5 (ja) |
| DE (1) | DE3728499A1 (ja) |
| DK (1) | DK171392B1 (ja) |
| FI (1) | FI873727A (ja) |
| FR (1) | FR2605222B1 (ja) |
| GB (1) | GB2195532B (ja) |
| HK (1) | HK64993A (ja) |
| IE (1) | IE60601B1 (ja) |
| IT (1) | IT1211477B (ja) |
| LU (1) | LU86973A1 (ja) |
| NL (1) | NL8701994A (ja) |
| NO (1) | NO873571L (ja) |
| NZ (1) | NZ221564A (ja) |
| SE (1) | SE502323C2 (ja) |
| SG (1) | SG52393G (ja) |
| ZA (1) | ZA876401B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736529A (en) * | 1996-03-22 | 1998-04-07 | Neurocal International Inc. | Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration |
| US6329349B1 (en) * | 1997-10-23 | 2001-12-11 | Trustees Of The University Of Pennsylvania | Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents |
| WO2000067754A1 (en) | 1999-05-12 | 2000-11-16 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| CN107773545A (zh) | 2016-08-29 | 2018-03-09 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1562962A (en) * | 1976-04-02 | 1980-03-19 | Chugai Pharmaceutical Co Ltd | Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same |
| US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
| EP0223811A1 (en) * | 1985-05-22 | 1987-06-03 | Beecham Group Plc | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease |
| US4696934A (en) * | 1986-01-10 | 1987-09-29 | Warner-Lambert Company | Method for using nifedipine for treating stroke |
| WO1987005508A1 (en) * | 1986-03-14 | 1987-09-24 | Medical College Of Wisconsin Research Foundation, | Method of treatment and prevention of cerebral vasospasms |
-
1987
- 1987-08-19 IE IE221887A patent/IE60601B1/en not_active IP Right Cessation
- 1987-08-21 IT IT8767725A patent/IT1211477B/it active
- 1987-08-21 AU AU77311/87A patent/AU603375B2/en not_active Ceased
- 1987-08-24 NO NO873571A patent/NO873571L/no unknown
- 1987-08-24 US US07/089,044 patent/US4870090A/en not_active Expired - Lifetime
- 1987-08-25 DK DK441987A patent/DK171392B1/da not_active IP Right Cessation
- 1987-08-25 NZ NZ221564A patent/NZ221564A/xx unknown
- 1987-08-26 LU LU86973A patent/LU86973A1/fr unknown
- 1987-08-26 SE SE8703308A patent/SE502323C2/sv not_active IP Right Cessation
- 1987-08-26 DE DE19873728499 patent/DE3728499A1/de not_active Withdrawn
- 1987-08-26 KR KR1019870009346A patent/KR950002151B1/ko not_active IP Right Cessation
- 1987-08-26 FR FR878711957A patent/FR2605222B1/fr not_active Expired - Fee Related
- 1987-08-26 BE BE8700948A patent/BE1003959A5/fr not_active IP Right Cessation
- 1987-08-26 CA CA000545418A patent/CA1302888C/en not_active Expired - Fee Related
- 1987-08-26 NL NL8701994A patent/NL8701994A/nl active Search and Examination
- 1987-08-27 CH CH3298/87A patent/CH672069A5/de not_active IP Right Cessation
- 1987-08-27 ZA ZA876401A patent/ZA876401B/xx unknown
- 1987-08-27 GB GB8720219A patent/GB2195532B/en not_active Expired - Fee Related
- 1987-08-27 FI FI873727A patent/FI873727A/fi not_active Application Discontinuation
- 1987-08-27 JP JP62213808A patent/JPH07121863B2/ja not_active Expired - Fee Related
-
1993
- 1993-04-23 SG SG52393A patent/SG52393G/en unknown
- 1993-07-08 HK HK649/93A patent/HK64993A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BE1003959A5 (fr) | 1992-07-22 |
| KR950002151B1 (ko) | 1995-03-14 |
| GB8720219D0 (en) | 1987-10-07 |
| IE872218L (en) | 1988-02-27 |
| DE3728499A1 (de) | 1988-03-03 |
| FI873727A (fi) | 1988-02-28 |
| SE8703308D0 (sv) | 1987-08-26 |
| CA1302888C (en) | 1992-06-09 |
| IT1211477B (it) | 1989-11-03 |
| NO873571D0 (no) | 1987-08-24 |
| AU603375B2 (en) | 1990-11-15 |
| SE8703308L (sv) | 1988-02-28 |
| DK441987D0 (da) | 1987-08-25 |
| IT8767725A0 (it) | 1987-08-21 |
| LU86973A1 (fr) | 1987-12-16 |
| IE60601B1 (en) | 1994-07-27 |
| GB2195532B (en) | 1990-05-23 |
| KR880002525A (ko) | 1988-05-09 |
| SG52393G (en) | 1993-08-06 |
| FR2605222A1 (fr) | 1988-04-22 |
| DK441987A (da) | 1988-02-28 |
| ZA876401B (en) | 1988-04-27 |
| NZ221564A (en) | 1999-08-30 |
| JPH07121863B2 (ja) | 1995-12-25 |
| HK64993A (en) | 1993-07-16 |
| FR2605222B1 (fr) | 1991-02-22 |
| DK171392B1 (da) | 1996-10-14 |
| US4870090A (en) | 1989-09-26 |
| CH672069A5 (ja) | 1989-10-31 |
| AU7731187A (en) | 1988-03-03 |
| JPS63152317A (ja) | 1988-06-24 |
| FI873727A0 (fi) | 1987-08-27 |
| NO873571L (no) | 1988-02-29 |
| GB2195532A (en) | 1988-04-13 |
| SE502323C2 (sv) | 1995-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW580385B (en) | Pharmaceutical composition for reducing insulin resistance in humans in whom impaired glucose tolerance and non-insulin dependent diabetes mellitus have not presented | |
| RU2394580C2 (ru) | Способы лечения митохондриальных нарушений | |
| JPH0714867B2 (ja) | 老化抑制の為の薬剤組成物 | |
| JP2721507B2 (ja) | 糖尿病治療剤 | |
| US3885035A (en) | Method for treating arrhythmia by using 1,4-bis(4 quinazolinyl) piperazines | |
| EP0808166A1 (fr) | Medicament destine au traitement des troubles obsessifs compulsifs, de l'apnee du sommeil, des dysfonctions sexuelles, de l'emese et du mal des transports | |
| JPS63270626A (ja) | 抗潰瘍剤 | |
| US3954988A (en) | Use of lisuride and physiologically acceptable salts thereof to achieve psychic energizer effects | |
| HU219589B (hu) | Eljárás uracil reduktáz enzimet inaktiváló anyagokat tartalmazó gyógyászati készítmények előállítására, és ilyen vegyületeket tartalmazó gyógyászati készítmények előállítására | |
| NL8701994A (nl) | Toepassing van n-(2-hydroxyethyl)nicotinamidenitraat of een farmaceutisch acceptabel zout hiervan ter bereiding van een geneesmiddel. | |
| NL194430C (nl) | Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking. | |
| US4088778A (en) | Method for the treatment of hypertension | |
| US4794111A (en) | Dihydropyridine preparations containing β-blockers | |
| US3362879A (en) | Tyrosine tranquilizing compositions and methods of treatment | |
| WO1999036068A1 (fr) | Activateurs des canaux de potassium | |
| JPH02193922A (ja) | 細胞保護用組成物 | |
| JP3061445B2 (ja) | 血管拡張剤 | |
| JPS63198630A (ja) | 脂質代謝改善剤 | |
| Clark et al. | The effect of tryptophan and a tryptophan/5-hydroxytryptophan combination on indoles in the brains of rats fed a tryptophan deficient diet | |
| US3969525A (en) | Method for reducing the heart beat frequency | |
| GB2234898A (en) | Oral pharmaceutical dosage form improving bioavailability | |
| MXPA05000451A (es) | Composicion medicinal para neuropatia inducida por farmaco. | |
| US3749781A (en) | Pharmaceutical composition and method of treatment | |
| WO1997042945A1 (en) | Oral pharmaceutical compositions | |
| JPH0643337B2 (ja) | コリン・アセチル転移酵素活性賦活剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BN | A decision not to publish the application has become irrevocable |